CELLULAR PATHOLOGY
Many business cases for digital pathology have focused on image acquisition and management, but laboratories also need to consider how to implement the new digital workflows and how to support the
clinicians who will be reporting the cases
Maintaining pathology information centrally is essential for management reporting and business intelligence. One example of management reporting for cellular pathology is the submission of data to the national cancer registry.
pathology projects must consider how reporters transition to digital, as not all reporters are ready at the same time. An LI- driven workflow can accommodate both glass and digital workstreams to encourage adoption and a phased transition to digital operation.
Specimen processing Specimen processing is already well established in the UK, managing the routing, tracking and quality assurance of specimen procedures with numerous integrations to cellular pathology workflow management and digital pathology systems. The next two releases of specimen processing provide in- module tracking without a workflow management system and light up the VUE diagnostic console, which Clinisys is launching in the UK as a reporting hub for clinicians during the first half of 2023.
Better reporting efficiency VUE aggregates diagnostic information from multiple systems on to a single screen, including digital pathology, which increases reporting efficiency as there are fewer clinical systems to interact with. This means that many more cases can be reported each day. It also reduces friction to adopt digital technology as the reporter feels like they are reporting in one system.
Perhaps surprisingly, not all digital solutions guarantee a paperless workflow. The WinPath solution, including specimen processing and VUE, facilitates paperless extra test requesting and processing as the reporter and laboratory maintain an
intrinsic link with the LIS. Additionally, from the pre- to the post-analytical phases, a match between sample and case is assured due to organic integration throughout the LIS with the patient record at the heart.
Management reporting Maintaining pathology information centrally is essential for management reporting and business intelligence. One example of management reporting for cellular pathology is the submission of data to the national cancer registry, the Cancer Outcome and Services Dataset (COSD). Both VUE and WinPath integrate with the new Clinisys partner application, mTuitive xPert. xPert captures synoptic data for reporting and simultaneously manages COSD submission with no user intervention. COSD collection and submission to the national cancer registry can be challenging without the WinPath system as it requires combining data in the LIS about the patient and reporter and information from the case report which includes macroscopy, SNOMED CT and digital pathology.
SNOMED CT is a key component of the Unified Test List (UTL) that is strategically important for interoperability. The UTL should be considered by the mature pathology network at the same time as digital reporting; the ability to share digital images is only one element of interoperability.
The data pathology future Digital pathology is almost synonymous with cellular pathology right now, but the
WWW.PATHOLOGYINPRACTICE.COM JUNE 2023
reality is there are other disciplines that have been digital for years and there are other areas that would benefit equally too, it isn’t just about glass slides in histopathology. A prerequisite to a patient-centric
process is a multi-disciplinary approach. In time there will be information for the diagnostician available in a digital format for all elements of clinical support. Maintaining all pathology data in one place, the LIS, is a good starting point. When we are digital, we can think about AI. I think the UK is still figuring out where AI from digital images is most useful. For example, is it best to prioritise the worklist, for reflex testing or to screen- out cases. Whatever the use, Clinisys will be innovating at the middle of the digital pathology ecosystem for years to come, recognising that what feels novel now in pathology will be routine in coming years.
Jake Morrow is Product Manager at Clinisys. Jake is an experienced and certified Product Manager for IVD and technology-based products in healthcare. He has a scientific background with over 10 years’ laboratory experience which included holding a Guest Lecturing position for six years; delivering course content to the next generation of biomedical scientists.
Clinisys UK
01932 581 200
info-uk@clinisys.com
www.clinisys.com
41
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
